240 related articles for article (PubMed ID: 26425894)
1. Molecular Characterization of Murine Monoclonal Antibody Variable Regions Specific for Hepatitis B Surface Antigen.
Golsaz-Shirazi F; Amiri MM; Bahadori M; Bayat AA; Mohammadi H; Farid S; Maddah M; Khoshnoodi J; Zarnani AH; Jeddi-Tehrani M; Shokri F
Viral Immunol; 2015 Oct; 28(8):425-33. PubMed ID: 26425894
[TBL] [Abstract][Full Text] [Related]
2. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization and structural modeling of immunoglobulin variable regions from murine monoclonal antibodies specific for hepatitis B virus surface antigen.
Lohman KL; Kieber-Emmons T; Kennedy RC
Mol Immunol; 1993 Oct; 30(14):1295-306. PubMed ID: 7692242
[TBL] [Abstract][Full Text] [Related]
4. Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg).
Golsaz-Shirazi F; Amiri MM; Farid S; Bahadori M; Bohne F; Altstetter S; Wolff L; Kazemi T; Khoshnoodi J; Hojjat-Farsangi M; Chudy M; Jeddi-Tehrani M; Protzer U; Shokri F
Antiviral Res; 2017 Aug; 144():153-163. PubMed ID: 28641998
[TBL] [Abstract][Full Text] [Related]
5. Variable region gene utilization and mutation in a group of neutralizing murine anti-human immunodeficiency virus type 1 principal neutralizing determinant antibodies.
Pirofski LA; Thomas EK; Scharff MD
AIDS Res Hum Retroviruses; 1993 Jan; 9(1):41-9. PubMed ID: 7678971
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine.
Tajiri K; Ozawa T; Jin A; Tokimitsu Y; Minemura M; Kishi H; Sugiyama T; Muraguchi A
Antiviral Res; 2010 Jul; 87(1):40-9. PubMed ID: 20412816
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of group-specific a antigen in hepatitis B vaccines by anti-HBs/a monoclonal antibody.
Yamamoto H; Satoh T; Kiyohara T; Totsuka A; Moritsugu Y
Biologicals; 1997 Dec; 25(4):373-80. PubMed ID: 9467033
[TBL] [Abstract][Full Text] [Related]
8. [Preparation of anti HBs monoclonal antibody and its combination characterization to both wild-type HBsAg and immune escape mutant HBsAg].
Li FH; Zhang XY; Yan B; Zhang B; Huang YG; Zhang CY; Gong JS; Chen Y; Liu JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):594-6. PubMed ID: 18538091
[TBL] [Abstract][Full Text] [Related]
9. Localization of immunodominant epitopes within the "a" determinant of hepatitis B surface antigen using monoclonal antibodies.
Golsaz-Shirazi F; Mohammadi H; Amiri MM; Khoshnoodi J; Kardar GA; Jeddi-Tehrani M; Shokri F
Arch Virol; 2016 Oct; 161(10):2765-72. PubMed ID: 27439498
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of cross-reactive anti-myosin/anti-streptococcal mouse monoclonal antibodies.
Mertens NM; Galvin JE; Adderson EE; Cunningham MW
Mol Immunol; 2000 Oct; 37(15):901-13. PubMed ID: 11282394
[TBL] [Abstract][Full Text] [Related]
11. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
[TBL] [Abstract][Full Text] [Related]
12. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei.
Kim HS; Tsai S; Zou N; Lo SC; Wear DJ; Izadjoo MJ
J Immunol Methods; 2011 Feb; 365(1-2):101-9. PubMed ID: 21172353
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the heavy chain variable region genes of human hybridoma clones specific for coagulation factor VIII.
Gharagozlou S; Kardar GA; Rabbani H; Shokri F
Thromb Haemost; 2005 Dec; 94(6):1131-7. PubMed ID: 16411384
[TBL] [Abstract][Full Text] [Related]
14. Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity.
Zheng X; Weinberger KM; Gehrke R; Isogawa M; Hilken G; Kemper T; Xu Y; Yang D; Jilg W; Roggendorf M; Lu M
Virology; 2004 Nov; 329(2):454-64. PubMed ID: 15518823
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations.
Cooreman MP; van Roosmalen MH; te Morsche R; Sünnen CM; de Ven EM; Jansen JB; Tytgat GN; de Wit PL; Paulij WP
Hepatology; 1999 Nov; 30(5):1287-92. PubMed ID: 10534351
[TBL] [Abstract][Full Text] [Related]
16. Gene cloning, bacterial expression, in vitro refolding, and characterization of a single-chain Fv antibody against PreS1(21-47) fragment of HBsAg.
Yang X; Hu W; Li F; Xia H; Zhang Z
Protein Expr Purif; 2005 Jun; 41(2):341-8. PubMed ID: 15866720
[TBL] [Abstract][Full Text] [Related]
17. Sequences of the VH and VL regions of murine monoclonal antibodies against 3-fucosyllactosamine.
Kimura H; Cook R; Meek K; Umeda M; Ball E; Capra JD; Marcus DM
J Immunol; 1988 Feb; 140(4):1212-7. PubMed ID: 2893825
[TBL] [Abstract][Full Text] [Related]
18. An hepatitis B virus surface antigen specific single chain of variable fragment derived from a natural immune antigen binding fragment phage display library is specifically internalized by HepG2.2.15 cells.
Wen WH; Qin WJ; Gao H; Zhao J; Jia LT; Liao QH; Meng YL; Jin BQ; Yao LB; Chen SY; Yang AG
J Viral Hepat; 2007 Jul; 14(7):512-9. PubMed ID: 17576393
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
[TBL] [Abstract][Full Text] [Related]
20. Variable region gene segments of nine monoclonal antibodies specific to disialogangliosides (GD2, GD3) and their O-acetylated derivatives.
Cerato E; Birkle S; Portoukalian J; Mezazigh A; Chatal JF; Aubry J
Hybridoma; 1997 Aug; 16(4):307-16. PubMed ID: 9309421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
